Met Life Investment Management, LLC Invitae Corp Transaction History

Met Life Investment Management, LLC

$18 Billion
Q4 2024

54 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$1.05 - $1.63 $132,057 - $205,003	125,769 New	125,769 $142,000
Q1 2023 May 09, 2024	BUY	$1.2 - $2.73 $150,922 - $343,349	125,769 New	125,769 $170 Million
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $25,734 - $58,544	21,445 Added 20.56%	125,769 $169,000
Q4 2022 May 10, 2024	SELL	$1.71 - $3.61 $31,752 - $67,034	-18,569 Reduced 15.11%	104,324 $194,000
Q4 2022 Jun 14, 2023	SELL	$1.71 - $3.61 $36,670 - $77,416	-21,445 Reduced 17.05%	104,324 $194,000
Q4 2022 Mar 22, 2023	SELL	$1.71 - $3.61 $31,752 - $67,034	-18,569 Reduced 15.11%	104,324 $194,000
Q4 2022 Feb 15, 2023	SELL	$1.71 - $3.61 $31,752 - $67,034	-18,569 Reduced 15.11%	104,324 $194,000
Q3 2022 May 10, 2024	BUY	$1.9 - $8.63 $58,533 - $265,864	30,807 Added 33.45%	122,893 $302,000
Q3 2022 Jun 14, 2023	SELL	$1.9 - $8.63 $5,464 - $24,819	-2,876 Reduced 2.29%	122,893 $302,000
Q3 2022 Mar 22, 2023	BUY	$1.9 - $8.63 $58,533 - $265,864	30,807 Added 33.45%	122,893 $302,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $58,533 - $265,864	30,807 Added 33.45%	122,893 $302,000
Q2 2022 May 10, 2024	SELL	$2.13 - $9.01 $29,345 - $124,130	-13,777 Reduced 13.01%	92,086 $224,000
Q2 2022 Jun 20, 2023	SELL	$2.13 - $9.01 $71,744 - $303,483	-33,683 Reduced 26.78%	92,086 $224,000
Q2 2022 Mar 22, 2023	SELL	$2.13 - $9.01 $29,345 - $124,130	-13,777 Reduced 13.01%	92,086 $224,000
Q2 2022 Aug 11, 2022	SELL	$2.13 - $9.01 $29,345 - $124,130	-13,777 Reduced 13.01%	92,086 $225,000
Q1 2022 May 10, 2024	BUY	$6.28 - $15.59 $664,819 - $1.65 Million	105,863 New	105,863 $843,000
Q1 2022 Jun 20, 2023	SELL	$6.28 - $15.59 $125,009 - $310,334	-19,906 Reduced 15.83%	105,863 $843,000
Q1 2022 Mar 22, 2023	BUY	$6.28 - $15.59 $216,917 - $538,494	34,541 Added 48.43%	105,863 $843,000
Q1 2022 May 12, 2022	BUY	$6.28 - $15.59 $216,917 - $538,494	34,541 Added 48.43%	105,863 $844,000
Q4 2021 Jun 21, 2023	SELL	$14.7 - $28.67 $800,370 - $1.56 Million	-54,447 Reduced 43.29%	71,322 $1.09 Million
Q3 2021 Jun 21, 2023	SELL	$24.31 - $33.6 $1.32 Million - $1.83 Million	-54,447 Reduced 43.29%	71,322 $2.03 Million
Q2 2021 May 17, 2024	BUY	$26.09 - $40.4 $658,015 - $1.02 Million	25,221 Added 54.71%	71,322 $2.41 Million
Q2 2021 Jun 21, 2023	SELL	$26.09 - $40.4 $1.42 Million - $2.2 Million	-54,447 Reduced 43.29%	71,322 $2.41 Million
Q2 2021 Mar 22, 2023	BUY	$26.09 - $40.4 $658,015 - $1.02 Million	25,221 Added 54.71%	71,322 $2.41 Million
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $658,015 - $1.02 Million	25,221 Added 54.71%	71,322 $2.41 Million
Q1 2021 May 17, 2024	BUY	$33.06 - $56.93 $1.52 Million - $2.62 Million	46,101 New	46,101 $1.76 Million
Q1 2021 Jun 26, 2023	SELL	$33.06 - $56.93 $2.63 Million - $4.54 Million	-79,668 Reduced 63.34%	46,101 $1.76 Billion
Q4 2020 May 24, 2024	SELL	$39.09 - $57.4 $89,516 - $131,446	-2,290 Reduced 4.73%	46,101 $1.93 Million
Q4 2020 Jun 22, 2023	SELL	$39.09 - $57.4 $3.11 Million - $4.57 Million	-79,668 Reduced 63.34%	46,101 $1.93 Million
Q4 2020 Mar 22, 2023	SELL	$39.09 - $57.4 $89,516 - $131,446	-2,290 Reduced 4.73%	46,101 $1.93 Million
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $89,516 - $131,446	-2,290 Reduced 4.73%	46,101 $1.93 Million
Q3 2020 May 24, 2024	SELL	$28.43 - $44.67 $73,008 - $114,712	-2,568 Reduced 5.04%	48,391 $2.1 Billion
Q3 2020 Jun 26, 2023	SELL	$28.43 - $44.67 $2.2 Million - $3.46 Million	-77,378 Reduced 61.52%	48,391 $2.1 Million
Q3 2020 Mar 22, 2023	SELL	$28.43 - $44.67 $73,008 - $114,712	-2,568 Reduced 5.04%	48,391 $2.1 Million
Q3 2020 Nov 13, 2020	SELL	$28.43 - $44.67 $73,008 - $114,712	-2,568 Reduced 5.04%	48,391 $2.1 Million
Q2 2020 May 24, 2024	BUY	$11.71 - $30.29 $596,729 - $1.54 Million	50,959 New	50,959 $1.54 Billion
Q2 2020 Jun 26, 2023	SELL	$11.71 - $30.29 $876,025 - $2.27 Million	-74,810 Reduced 59.48%	50,959 $1.54 Million
Q2 2020 Mar 22, 2023	BUY	$11.71 - $30.29 $136,456 - $352,969	11,653 Added 29.65%	50,959 $1.54 Million
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $136,456 - $352,969	11,653 Added 29.65%	50,959 $1.54 Million
Q1 2020 Jul 12, 2023	SELL	$7.64 - $27.5 $660,577 - $2.38 Million	-86,463 Reduced 68.75%	39,306 $537,000
Q4 2019 Jul 12, 2023	SELL	$15.02 - $20.57 $1.3 Million - $1.78 Million	-86,463 Reduced 68.75%	39,306 $634,000
Q3 2019 Jul 12, 2023	SELL	$18.85 - $27.5 $1.63 Million - $2.38 Million	-86,463 Reduced 68.75%	39,306 $757,000
Q3 2019 Mar 22, 2023	BUY	$18.85 - $27.5 $146,426 - $213,620	7,768 Added 24.63%	39,306 $757,000
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $146,426 - $213,620	7,768 Added 24.63%	39,306 $757,000
Q2 2019 Jul 12, 2023	SELL	$17.37 - $26.27 $1.5 Million - $2.27 Million	-86,463 Reduced 68.75%	39,306 $923,000
Q1 2019 Jul 13, 2023	SELL	$10.65 - $25.75 $1 Million - $2.43 Million	-94,231 Reduced 74.92%	31,538 $738,000
Q4 2018 Jul 13, 2023	SELL	$9.26 - $16.38 $872,579 - $1.54 Million	-94,231 Reduced 74.92%	31,538 $348,000
Q4 2018 Mar 22, 2023	SELL	$9.26 - $16.38 $161,077 - $284,930	-17,395 Reduced 35.55%	31,538 $348,000
Q4 2018 Feb 14, 2019	SELL	$9.26 - $16.38 $161,077 - $284,930	-17,395 Reduced 35.55%	31,538 $349,000
Q3 2018 Jul 13, 2023	SELL	$7.54 - $18.31 $710,501 - $1.73 Million	-94,231 Reduced 74.92%	31,538 $527,000
Q3 2018 Mar 22, 2023	SELL	$7.54 - $18.31 $417,648 - $1.01 Million	-55,391 Reduced 53.1%	48,933 $818,000
Q3 2018 Nov 14, 2018	BUY	$7.54 - $18.31 $131,158 - $318,502	17,395 Added 55.16%	48,933 $819,000
Q2 2018 Aug 15, 2018	BUY	$4.87 - $8.42 $75,694 - $130,872	15,543 Added 97.17%	31,538 $232,000
Q4 2017 Feb 15, 2018	BUY	$7.86 - $9.99 $125,720 - $159,790	15,995	15,995 $145,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

1.92M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account